Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis

被引：0

作者：

Paller, Amy ^{[1
]}

Seyger, Marieke ^{[2
]}

Alejandro Magarinos, Gabriel ^{[3
]}

Bagel, Jerry ^{[4
]}

Keller, Stuart ^{[5
]}

Capriles, Claudia Rodriguez ^{[5
]}

Gallo, Gaia ^{[5
]}

Edson-Heredia, Emily ^{[5
]}

Li, Lingnan ^{[5
]}

Xu, Wen ^{[5
]}

Papp, Kim ^{[6
,7
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA

[2] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands

[3] Psoriahue, Buenos Aires, DF, Argentina

[4] Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA

[5] Eli Lilly & Co, Indianapolis, IN 46285 USA

[6] K Papp Clin Res & Prob Med Res, Waterloo, ON, Canada

[7] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2020年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P029

引用

页码：17 / 17

页数：1

共 50 条

[1] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and comorbid diabetes mellitus
Egeberg, A.
Schaekel, K.
Puig, L.
Saure, D.
Yali Wang, I.
Pavo, I.
Mahar, P.
Schuster, C.
Griffiths, C. E. M.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E31 - E31
[2] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes
Egeberg, Alexander
Merola, Joseph F.
Schaekel, Knut
Puig, Luis
Mahar, Patrick D.
Wang, Isabella Yali
Pavo, Imre
Schuster, Christopher
Griffiths, Christopher E. M.
[J]. FRONTIERS IN MEDICINE, 2023, 9
[3] Sustained Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis
Papp, Kim
Gottlieb, Alice B.
Shuler, Catherine L.
Burge, Russel T.
Cameron, Gregory
Kerr, Lisa
Mease, Philip J.
[J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
[4] Ixekizumab for the treatment of pediatric patients with moderate to severe plaque psoriasis
Cather, Jennifer Clay
Young, Chaney T.
Young, Melody S.
Cather, J. Christian
[J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (08) : 983 - 990
[5] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
Li Ying
Ji Suyun
Liang Yanhua
Liang Yunsheng
Deng Li
Dang Lin
Lv Chengzhi
Lin Bingjiang
Zhang Furen
Shi Wendi
Li Jinnan
Dong Yu
Dou Guanshen
Yuling Shi
[J]. Advances in Therapy, 2023, 40 : 5464 - 5474
[6] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
Ying, Li
Suyun, Ji
Yanhua, Liang
Yunsheng, Liang
Li, Deng
Lin, Dang
Chengzhi, Lv
Bingjiang, Lin
Furen, Zhang
Wendi, Shi
Jinnan, Li
Yu, Dong
Guanshen, Dou
Shi, Yuling
[J]. ADVANCES IN THERAPY, 2023, 40 (12) : 5464 - 5474
[7] Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis
Saeki, H.
Nakagawa, H.
Ishii, T.
Morisaki, Y.
Aoki, T.
Berclaz, P. -Y.
Heffernan, M.
[J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1148 - 1155
[8] Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium
Carmona-Rocha, Elena
Puig, Lluis
[J]. IMMUNOTHERAPY, 2023, 15 (15) : 1209 - 1225
[9] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Gordon, K. B.
Blauvelt, A.
Papp, K. A.
Langley, R. G.
Luger, T.
Ohtsuki, M.
Reich, K.
Amato, D.
Ball, S. G.
Braun, D. K.
Cameron, G. S.
Erickson, J.
Konrad, R. J.
Muram, T. M.
Nickoloff, B. J.
Osuntokun, O. O.
Secrest, R. J.
Zhao, F.
Mallbris, L.
Leonardi, C. L.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 345 - 356
[10] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Egeberg, Alexander
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2101 - 2102

← 1 2 3 4 5 →